SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000893220-06-002690
Filing Date
2006-12-21
Accepted
2006-12-21 17:26:56
Documents
9
Period of Report
2006-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q PAR PHARMACEUTICAL COMPANIES, INC. w26986e10vq.htm 10-Q 104183
2 EMPLOYMENT AGREEMENT BY & BETWEEN PAR PHARMACEUTICAL COMPANIES AND PATRICK LEPOR w26986exv10w1.htm EX-10.1 47264
3 SEPARATION AGREEMENT BY & BETWEEN PAR PHARMACEUTICALS & MARK AUERBACH w26986exv10w2.htm EX-10.2 40400
4 SEPARATION AGREEMENT BY & BETWEEN PAR PHARMACEUTICALS & MICHAEL GRAVES w26986exv10w3.htm EX-10.3 40293
5 SEPARATION AGREEMENT BY & BETWEEN PAR PHARMACEUTICALS & SHANKAR HARIHARAN w26986exv10w4.htm EX-10.4 39235
6 CERTIFICATION OF THE PRINCIPAL EXECUTIVE OFFICER w26986exv31w1.htm EX-31.1 1246
7 CERTIFICATION OF THE PRINCIPAL FINANCIAL OFFICER w26986exv31w2.htm EX-31.2 1248
8 CERTIFICATION BY THE CHIEF EXECUTIVE OFFICER w26986exv32w1.htm EX-32.1 1360
9 CERTIFICATION BY THE CHIEF FINANCIAL OFFICER w26986exv32w2.htm EX-32.2 1348
  Complete submission text file 0000893220-06-002690.txt   278088
Mailing Address 300 TICE BOULEVARD WOODCLIFF LAKE NJ 07677
Business Address 300 TICE BOULEVARD WOODCLIFF LAKE NJ 07677 845-425-7100
PAR PHARMACEUTICAL COMPANIES, INC. (Filer) CIK: 0000878088 (see all company filings)

IRS No.: 223122182 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-10827 | Film No.: 061294321
SIC: 2834 Pharmaceutical Preparations